Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Phase 2 Study of Efficacy and Safety of Pegylated Interferon-alfa 2a in Polycythemia Vera Patients

NCT00241241 is registered in ClinicalTrials.gov with PV-Nord as lead sponsor.

NCT NCT00241241
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00241241 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Phase 2 Study of Efficacy and Safety of Pegylated Interferon-alfa 2a in Polycythemia Vera Patients
Lead sponsor
PV-Nord
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2004
Completion date
January 31, 2008
Enrollment
40
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

polycythemia vera